Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Critical Illness
- Sepsis
- Type
- Observational
- Design
- Observational Model: OtherTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04755777
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Erin Barreto, Pharm. D.,R.Ph. Mayo Clinic